Analystreport

Adamas Pharmaceuticals Inc (NASDAQ: ADMS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors